Identification of a blood-based biomarker panel for classification of Alzheimer's disease.
暂无分享,去创建一个
Christoph Laske | Janko Dietzsch | Andreas J Fallgatter | Thomas Leyhe | A. Fallgatter | C. Laske | J. Dietzsch | T. Leyhe | Nadine Hoffmann | Elke Stransky | E. Stransky | N. Hoffmann
[1] C. Romualdi,et al. Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid‐induced increase in von Willebrand factor: the lesson learned from Cushing syndrome , 2007, British journal of haematology.
[2] D. Royall,et al. Alzheimer disease as a vascular disorder: nosological evidence. , 2002, Stroke.
[3] Michel Verleysen,et al. The Curse of Dimensionality in Data Mining and Time Series Prediction , 2005, IWANN.
[4] Ian H. Witten,et al. Data mining: practical machine learning tools and techniques, 3rd Edition , 1999 .
[5] Georg Kemmler,et al. Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease , 2011, Neurobiology of Aging.
[6] R. Tibshirani,et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins , 2007, Nature Medicine.
[7] J. C. Torre,et al. Alzheimer Disease as a Vascular Disorder: Nosological Evidence , 2002 .
[9] A. Remes,et al. Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease , 2009, Neurobiology of Disease.
[10] F. Cohen,et al. Biochemistry and genetics of von Willebrand factor. , 1998, Annual review of biochemistry.
[11] K. Blennow,et al. CSF markers for incipient Alzheimer's disease , 2003, The Lancet Neurology.
[12] C. Laske,et al. Decreased plasma levels of granulocyte-colony stimulating factor (G-CSF) in patients with early Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.
[13] T. Berzin,et al. Microvascular injury and blood–brain barrier leakage in Alzheimer's disease , 2007, Neurobiology of Aging.
[14] P. Grant,et al. Risk factors for cerebrovascular disease and the role of coagulation and fibrinolysis. , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[15] H. Benali,et al. Support vector machine-based classification of Alzheimer’s disease from whole-brain anatomical MRI , 2009, Neuroradiology.
[16] 赤座 至. Endothelial dysfunction associated with hypercortisolism is reversible in Cushing's syndrome , 2010 .
[17] C. Laske,et al. Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Aβ 1–42 ratios in CSF in patients with mild Alzheimer’s disease dementia , 2009, European Archives of Psychiatry and Clinical Neuroscience.
[18] Trevor Hastie,et al. The Elements of Statistical Learning , 2001 .
[19] F. LaFerla,et al. Alzheimer's disease. , 2010, The New England journal of medicine.
[20] A. Fagan,et al. Plasma Cortisol and Progression of Dementia in DAT Subjects , 2006 .
[21] Thomas Lengauer,et al. ROCR: visualizing classifier performance in R , 2005, Bioinform..
[22] Berislav V. Zlokovic,et al. Neurovascular mechanisms of Alzheimer's neurodegeneration , 2005, Trends in Neurosciences.
[23] Salvatore Musumeci,et al. Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status , 2004, Clinical chemistry and laboratory medicine.
[24] D. Ryglewicz,et al. Antibodies against oxidized LDL and apolipoprotein E polymorphism in demented patients , 2009, Journal of the Neurological Sciences.
[25] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.
[26] L. Parnetti,et al. Hemostasis Abnormalities in Patients with Vascular Dementia and Alzheimer’s Disease , 1996, Thrombosis and Haemostasis.
[27] Ian Witten,et al. Data Mining , 2000 .
[28] T. Yoshimoto,et al. Endothelial dysfunction aassociated with hypercortisolism is reversible in Cushing's syndrome. , 2010, Endocrine journal.
[29] A. Fagan,et al. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. , 2006, The American journal of psychiatry.
[30] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[31] Michel Verleysen,et al. Nonlinear Dimensionality Reduction , 2021, Computer Vision.
[32] Pablo Moscato,et al. Identification of a 5-Protein Biomarker Molecular Signature for Predicting Alzheimer's Disease , 2008, PloS one.
[33] W. Maetzler,et al. Macrophage colony-stimulating factor (M-CSF) in plasma and CSF of patients with mild cognitive impairment and Alzheimer's disease. , 2010, Current Alzheimer research.
[34] S. Soekadar,et al. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls. , 2007, Journal of psychiatric research.
[35] C. Laske,et al. Decreased CXCL12 (SDF-1) plasma levels in early Alzheimer's disease: a contribution to a deficient hematopoietic brain support? , 2008, Journal of Alzheimer's disease : JAD.
[36] H. Vankova. Mini Mental State , 2010 .
[37] Takashi Takenouchi,et al. Statistical Learning Theory by Boosting Method , 2004 .
[38] C. Laske,et al. Decreased plasma and cerebrospinal fluid levels of stem cell factor in patients with early Alzheimer's disease. , 2008, Journal of Alzheimer's disease : JAD.
[39] J. Ryu,et al. A leaky blood–brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer’s disease brain , 2008, Journal of cellular and molecular medicine.